Newsletters

  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
All
  • All
  • AMR Action Fund
  • Can you help?
  • CARB-X
  • CDC
  • FDA
  • Government Action
  • Jobs
  • Meetings
  • PK & PK-PD
  • Push/Pull
  • R&D Insight
  • RFPs
  • Something Different
  • Summaries
  • Wellcome Trust
  • WHO
  • Wonkish
R&D Insight

HERA: 13m EUR call for rapid point-of-care susceptibility devices

Dear All, You can’t actually submit your application until ~4 April 2025, but I’ve learned that EU’s HERA (Health Emergency
Read More >
R&D Insight

EMA: 16m EUR to fund regulatory science research

Dear All, EMA have recently posted a call for tenders under which they seek to “procure the services of research
Read More >
R&D Insight

Sign-on Letter to Preserve Upcoming ACIP Meeting

Dear All, The Advisory Committee on Immunization Practices (ACIP) is scheduled to meet 26-28 Feb 2025 (see links below my signature
Read More >
R&D Insight

ESCMID 2025: Science Policy Forum and Pipeline Day events

Dear All, If you are attending ESCMID Global in Vienna this year, mark your calendar for two major events. I
Read More >
R&D Insight

Gates/Novo Nordisk/Wellcome Grand Challenge: Gr-ADI, the Gram-Negative Antibiotic Discovery Innovator

Dear All, A huge announcement today backed by the combined power of the Gates Foundation, Novo Nordisk, and Wellcome! I
Read More >
R&D Insight

Jan 2025 PACCARB meeting cancelled as new administration takes the reins

Dear All, Sadly, I must report that the 27th meeting of PACCARB (the US Presidential Advisory Council on Combatting Antibiotic-Resistant
Read More >
R&D Insight

NOHF-Zoonoses, NARMS, and more: US action on One Health, Surveillance, and much more

Dear All, Three things for today along with some great acronyms! To start, we have an announcement of the first
Read More >
R&D Insight

Italy delivers a national pull incentive (with a budget of EUR 100 million a year)!

Dear All (and with thanks to Damiano for taking the lead on this newsletter), We start the new year with good
Read More >
R&D Insight

WHO-GARDP: Policy interventions for (mostly acute) antibiotic shortages

Dear All, I wrote in the 1 Dec 2024 newsletter about the excellent paper by Baraldi et al. that introduced
Read More >
R&D InsightWonkish

Mirror Bacteria: An AMR threat of unprecedented magnitude

Dear All (wonkish but stick with it … I’m going to try very hard to de-wonk it), In an absolutely
Read More >
R&D Insight

(Re)using surveillance data: 2024 Vivli Challenge Awardees

Dear All, I’ve written before about the Vivli AMR Surveillance Data Challenge that seeks creative ways to reuse MICs from surveillance
Read More >
Government ActionSomething Different

The 6 meanings of “Lack of Access” (UNSLAP)

Dear All, We often talk about the problem of lack of access to new antibiotics. In late 2021, for example, we
Read More >
R&D Insight

NIAID/DMID call for antibacterials, antifungals, vaccines, & diagnostics

Dear All, Just released, the 2026 NIAID DMID Omnibus Broad Agency Announcement (HHS-NIH-NIAID-BAA2025-1) seeks applications for projects to treat, prevent,
Read More >
Government ActionPush/Pull

Sign a letter to help #PassPASTEUR!

Dear All,  MyCARE, a fungal patient advocacy organization, and the Partnership to Fight Infectious Diseases (PFID), are sending a letter
Read More >
Government ActionPush/Pull

Global Leaders Group on AMR has vacancies!

Dear All,  The Global Leaders Group on Antimicrobial Resistance (GLG AMR) chaired by Her Excellency Prime Minister Mia Amor Mottley of Barbados is
Read More >
Government ActionR&D Insight

WHO AMR Survivor Task Force: Fireside Chat

Dear All, Back in 2022, I wrote a newsletter about the World Health Organization putting out a call to form
Read More >
Government ActionPush/Pull

G20 Health Ministers: Let’s take action on AMR!

Dear All, As we’ve discussed previously (1 Oct 2024 newsletter), the HLM on AMR at UNGA 2024 is but one
Read More >
Government ActionPush/Pull

BARDA seeks deep insight on antibacterials near/beyond end-of-Phase 2

Dear All, BARDA has released a fascinating Sources Sought Notice (SSN) seeking data on antibacterials near, at, or beyond Phase 2.
Read More >
R&D Insight

NIAID RFA: Centers for Accelerating Phage Therapy (CAPT-CEP)

Dear All, I was delighted to learn today that NIAID has released RFA-AI-24-069, a notice of funding opportunity (NOFO) soliciting applications
Read More >
R&D Insight

Vivli: Access to Industry’s Susceptibility Surveillance data

Dear All (and with thanks to Patricia Bradford for leading on this newsletter), Did you know you can access raw
Read More >
Scroll to Top